insulin glargine · Lantus

Peptide

Approvedregulatory verdict

Evidence outlook

Approved: Type 2 Diabetes, Type 1 Diabetes

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Partial signal

Also approved (1)
EU
  • Diabetes mellitus requiring insulin (Lantus, sanofi-aventis Deutschland GmbH)
Product first approved 2000EMA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (134)
Type 1 Diabetes
NCT07282054 · Tonghua Dongbao Pharmaceutical Co.,Ltd
2022-04-13 – 2025-01-24 · Type 1 Diabetes
What this study did
NCT07070752 · Geropharm
2023-04-14 – 2023-11-28 · Type 1 Diabetes Mellitis
What this study did
NCT03952130 · Eli Lilly and Company
2019-05-29 – 2022-01-10 · Type 1 Diabetes Mellitus
What this study did
NCT03874715 · Sanofi
2019-03-11 – 2020-07-08 · Type 1 Diabetes Mellitus
What this study did
NCT03214367 · Eli Lilly and Company
2017-07-17 – 2019-08-22 · Type 1 Diabetes Mellitus
What this study did
NCT01194882 · Sanofi
2010-11-16 – 2018-02-01 · Diabetes Mellitus, Type 1
What this study did
NCT02273180 · Sanofi
2014-10 – 2016-07 · Type 1 Diabetes Mellitus
What this study did
NCT02518945 · University at Buffalo
2015-08 – 2016-04 · Type 1 Diabetes Mellitus
What this study did
NCT02034513 · Novo Nordisk A/S
2014-01-05 – 2016-01-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01223131 · Sanofi
2011-02 – 2014-03 · Type 1 Diabetes Mellitus
What this study did
NCT01192711 · Consorzio Mario Negri Sud
2009-05 – 2011-10 · Type 1 Diabetes
What this study did
NCT00993473 · Sanofi
2009-10 – 2011-03 · Type 1 Diabetes Mellitus
What this study did
NCT00694122 · Massachusetts General Hospital
2005-06 – 2010-11 · Type 1 Diabetes, Dawn Phenomenon
What this study did
NCT00127634 · Eli Lilly and Company
2005-07 – 2008-05 · Diabetes Mellitus, Type 1
What this study did
NCT00356109 · Eli Lilly and Company
2006-08 – 2008-05 · Diabetes Mellitus, Type 1
What this study did
NCT00115570 · Sanofi
2005-04 – 2006-11 · Diabetes Mellitus, Insulin-Dependent
What this study did
NCT00095082 · Novo Nordisk A/S
2004-09 – 2005-12 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00272090 · Sanofi
2002-11 – 2005-12 · Diabetes Mellitus, Type 1
What this study did
NCT00046501 · Sanofi
2002-11 – 2005-02 · Diabetes Mellitus
What this study did
NCT00004984 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
1994-02 – 2003-06 · Diabetes Mellitus, Type 1
What this study did
NCT00312104 · Novo Nordisk A/S
2002-04 – 2003-03 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT06619301 · Loyola University
2024-04-01 – 2027-01-01 · Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM), Gestational Diabetes Mellitus, Class A2
What this study did
NCT06881264 · Jiangsu HengRui Medicine Co., Ltd.
2024-04-30 – 2025-09-19 · Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs
What this study did
NCT04974528 · Mannkind Corporation
2021-09-29 – 2025-04-29 · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
What this study did
NCT06107153 · University of Basrah
2023-11-01 – 2024-11-01 · Type2diabetes
What this study did
NCT05662332 · Eli Lilly and Company
2023-01-14 – 2024-07-19 · Type 2 Diabetes, T2D
What this study did
NCT05545800 · Xiangya Hospital of Central South University
2022-09-01 – 2024-06-01 · Type 2 Diabetes Mellitus
What this study did
NCT05462756 · Eli Lilly and Company
2022-08-11 – 2024-02-27 · Type 2 Diabetes, Type 2 Diabetes Treated With Insulin
What this study did
NCT05413369 · Sanofi
2022-07-07 – 2023-10-20 · Type 2 Diabetes Mellitus
What this study did
NCT04460326 · Boston Medical Center
2020-12-07 – 2023-05-27 · Type 2 Diabetes Treated With Insulin
What this study did
NCT04605991 · Eli Lilly and Company
2020-11-04 – 2022-02-04 · Type 2 Diabetes
What this study did
NCT02194595 · Mount Sinai Hospital, Canada
2014-09 – 2022-02 · Type 2 Diabetes
What this study did
NCT01794143 · GRADE Study Group
2013-05 – 2021-04-30 · Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications
What this study did
NCT03689374 · Novo Nordisk A/S
2018-10-01 – 2021-02-22 · Diabetes Mellitus, Type 2
What this study did
NCT03952143 · Eli Lilly and Company
2019-05-27 – 2021-01-20 · Type 2 Diabetes Mellitus
What this study did
NCT03130426 · Population Health Research Institute
2017-06-27 – 2020-09-30 · Type 2 Diabetes Mellitus
What this study did
NCT02192424 · Mount Sinai Hospital, Canada
2014-07 – 2020-09 · Type 2 Diabetes
What this study did
NCT02623998 · Population Health Research Institute
2016-07-09 – 2019-11-30 · Type 2 Diabetes Mellitus
What this study did
NCT03529123 · Sanofi
2018-06-19 – 2019-11-25 · Type 2 Diabetes Mellitus
What this study did
NCT01779362 · RISE Study Group
2013-04 – 2019-08 · Prediabetes, Type 2 Diabetes
What this study did
NCT02752113 · Institut für Pharmakologie und Präventive Medizin
2016-04 – 2019-05 · Diabetes Mellitus Type 2
What this study did
NCT03214380 · Eli Lilly and Company
2017-07-14 – 2019-03-13 · Type 2 Diabetes Mellitus
What this study did
Phase 2/3 (1)
Type 1 Diabetes
NCT00447213 · Eli Lilly and Company
2007-04 – 2008-05 · Diabetes Mellitus, Type 1
What this study did
Phase 2 (20)
Type 1 Diabetes
NCT01194245 · Halozyme Therapeutics
2010-08 – 2011-08 · Diabetes Mellitus, Type 1
What this study did
NCT01049412 · Eli Lilly and Company
2010-01 – 2011-01 · Diabetes Mellitus, Type 1
What this study did
NCT00883558 · Halozyme Therapeutics
2009-05 – 2010-04 · Diabetes Mellitus, Type 1
What this study did
NCT00612040 · Novo Nordisk A/S
2008-01 – 2008-06 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT04542148 · University of Alabama at Birmingham
2022-02-10 – 2026-12-31 · Diabetes Mellitus, Type 2, Preterm Birth, Pregnancy, High Risk, Diabetes, Gestational
What this study did
NCT03922750 · Novo Nordisk A/S
2019-05-09 – 2020-01-27 · Diabetes Mellitus, Type 2
What this study did
NCT03751657 · Novo Nordisk A/S
2018-11-29 – 2020-01-17 · Diabetes Mellitus, Type 2
What this study did
NCT03951805 · Novo Nordisk A/S
2019-05-09 – 2020-01-17 · Diabetes Mellitus, Type 2
What this study did
NCT02470039 · Novo Nordisk A/S
2015-06-01 – 2015-12-31 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01399645 · Centre hospitalier de l'Université de Montréal (CHUM)
2011-05 – 2014-06 · Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Type 2 Diabetes
What this study did
NCT01011868 · Boehringer Ingelheim
2009-11 – 2012-05 · Diabetes Mellitus, Type 2
What this study did
NCT01194258 · Halozyme Therapeutics
2010-08 – 2011-08 · Diabetes Mellitus, Type II
What this study did
NCT00850096 · CPEX Pharmaceuticals Inc.
2009-01 – 2010-03 · Type 2 Diabetes
What this study did
Other / comorbidity
NCT07461103 · Alexandria University
2024-06-22 – 2025-08-10 · Pemphigus Vulgaris, Skin Erosion, Autoimmune Blistering Disease
What this study did
NCT06007508 · HealthPartners Institute
2022-05-31 – 2023-02-28 · DKA
What this study did
NCT01910194 · Profil Institut für Stoffwechselforschung GmbH
2013-12 – 2014-10 · Diabetes Mellitus
What this study did
NCT00764556 · St George's, University of London
2008-05 – 2009-05 · COPD, Hyperglycemia
What this study did
NCT01000922 · Biodel
2006-06 – 2008-01 · Diabetes Mellitus
What this study did
Phase 1/2 (1)
Type 1 Diabetes
NCT01053728 · Sanofi
2010-02 – 2010-11 · Type 1 Diabetes Mellitus
What this study did
Phase 1 (47)
Type 1 Diabetes
NCT04236895 · Gan and Lee Pharmaceuticals, USA
2018-07-10 – 2018-11-28 · Diabetes Mellitus, Type 1
What this study did
NCT02506647 · Gan and Lee Pharmaceuticals, USA
2015-12 – 2016-09 · Diabetes Mellitus, Type 1
What this study did
NCT02059174 · Merck Sharp & Dohme LLC
2014-02-10 – 2015-04-27 · Type 1 Diabetes Mellitus
What this study did
NCT02220296 · Novo Nordisk A/S
2014-08-20 – 2015-03-31 · Healthy, Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01838083 · Sanofi
2013-04 – 2013-08 · Type1 Diabetes
What this study did
NCT01704417 · Novo Nordisk A/S
2012-10 – 2013-03 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01357603 · Wockhardt
2011-06 – 2012-08 · Type1 Diabetes
What this study did
NCT01493115 · Sanofi
2011-11 – 2012-04 · Type 1 Diabetes Mellitus
What this study did
NCT01349855 · Sanofi
2011-03 – 2011-05 · Type 1 Diabetes Mellitus
What this study did
NCT01146678 · Sanofi
2010-06 – 2011-01 · Type 1 Diabetes Mellitus
What this study did
NCT01195454 · Sanofi
2010-08 – 2010-12 · Type 1 Diabetes Mellitus
What this study did
NCT00961324 · Novo Nordisk A/S
2009-07-27 – 2009-10-26 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01868529 · Novo Nordisk A/S
2008-01 – 2008-06 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01497574 · Novo Nordisk A/S
2005-05 – 2005-10 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT03945656 · Novo Nordisk A/S
2019-05-07 – 2021-09-27 · Diabetes Mellitus, Type 2
What this study did
NCT02803918 · Sanofi
2017-05-17 – 2020-01-27 · Type 2 Diabetes Mellitus
What this study did
NCT03170544 · Merck Sharp & Dohme LLC
2017-08-16 – 2018-11-08 · Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
What this study did
NCT02713477 · Sanofi
2016-04 – 2016-06 · Type 2 Diabetes Mellitus
What this study did
NCT02479022 · Novo Nordisk A/S
2015-06 – 2015-12 · Diabetes, Diabetes Mellitus, Type 2, Healthy
What this study did
NCT02012465 · Washington University School of Medicine
2013-09 – 2015-05 · Lymphoma, Diabetes Mellitus, Type 2, Hyperglycemia
What this study did
NCT01809184 · Novo Nordisk A/S
2013-03-04 – 2013-09-06 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01796366 · Novo Nordisk A/S
2013-02-21 – 2013-08-19 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01597713 · Novo Nordisk A/S
2012-05 – 2012-10 · Diabetes, Diabetes Mellitus, Type 2, Healthy
What this study did
NCT00574912 · Vanderbilt University Medical Center
2007-03 – 2010-01 · Type 2 Diabetes
What this study did
NCT00971659 · Profil Institut für Stoffwechselforschung GmbH
2008-01 – 2008-11 · Type 2 Diabetes
What this study did
NCT00511472 · Merck Sharp & Dohme LLC
2007-07 – 2008-04 · Type 2 Diabetes Mellitus
What this study did
NCT00824668 · Novo Nordisk A/S
2007-08 – 2007-10 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00184613 · Novo Nordisk A/S
2005-05 – 2006-01 · Diabetes, Diabetes Mellitus, Type 2, Delivery Systems
What this study did
Other / comorbidity
NCT02587741 · Third Affiliated Hospital, Sun Yat-Sen University
2015-07 – 2025-07 · Diabetic Retinopathy
What this study did
NCT07588906 · Jiangsu HengRui Medicine Co., Ltd.
2024-02-26 – 2024-07-23 · Healthy Subjects
What this study did
NCT03904199 · H. Lee Moffitt Cancer Center and Research Institute
2019-04-04 – 2021-11-02 · Hyperglycemia
What this study did
NCT01688635 · Eli Lilly and Company
2012-09 – 2013-02 · Healthy
What this study did
NCT01634165 · Eli Lilly and Company
2012-07 – 2012-09 · Healthy Volunteers
What this study did
NCT01476345 · Eli Lilly and Company
2011-11 – 2012-07 · Diabetes Mellitus
What this study did
NCT01152242 · Merck Sharp & Dohme LLC
2010-08 – 2012-05 · Diabetes
What this study did
NCT01153100 · University of Colorado, Denver
2010-04 – 2012-02 · Diabetes
What this study did
NCT01334034 · Novo Nordisk A/S
2011-04-11 – 2011-09-16 · Diabetes, Healthy
What this study did
NCT00652288 · Yale University
2007-04 – 2011-09 · Diabetes Mellitus, Type I
What this study did
NCT01002768 · Novo Nordisk A/S
2009-10 – 2010-03 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00348972 · Sanofi
started 2002-02 · Hyperglycemia, Diabetes Mellitus
What this study did
Phase 4 (207)
Type 1 Diabetes
NCT03463564 · University of Campania Luigi Vanvitelli
2016-01 – 2026-12 · Type 1 Diabetes Mellitus
What this study did
NCT07872475 · Marmara University
2025-05-01 – 2026-05-01 · Type 1 Diabetes Mellitus
What this study did
NCT05614089 · Jing Luo
2023-03-15 – 2025-03-19 · Diabetes Mellitus, Type 1, Type 1 Diabetes
What this study did
NCT06717191 · Life for a Child Program, Diabetes Australia
2022-06-09 – 2024-08-02 · Type 1 Diabetes
What this study did
NCT04623086 · University of Washington
2020-02-14 – 2023-12-31 · Type 1 Diabetes
What this study did
NCT06624943 · Life for a Child Program, Diabetes Australia
2022-03-14 – 2023-05-05 · Type 1 Diabetes (T1D)
What this study did
NCT05709938 · King Edward Medical University
2019-11-01 – 2021-04-20 · To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
What this study did
NCT03107208 · University of Colorado, Denver
2017-07-21 – 2021-03-13 · Diabetic Ketoacidosis, Type 1 Diabetes Mellitus
What this study did
NCT04664764 · Ain Shams University
2019-02-21 – 2021-03-10 · Type 1 Diabetes Mellitus With Hypoglycemia, type1diabetes
What this study did
NCT04157738 · Emory University
2019-11-27 – 2020-12-17 · Diabetes Mellitus, Type 1 Diabetes
What this study did
NCT03260868 · Sanofi
2017-09-19 – 2018-11-22 · Type 1 Diabetes Mellitus
What this study did
NCT03312478 · Sanofi
2017-10-13 – 2018-08-19 · Type 1 Diabetes
What this study did
NCT01204593 · Sanofi
2010-11 – 2013-01 · Diabetes Mellitus, Type 1
What this study did
NCT01440439 · Buckinghamshire Healthcare NHS Trust
2011-11 – 2012-06 · Diabetes Mellitus, Type 1
What this study did
NCT00964574 · Sanofi
2009-07 – 2010-07 · Diabetes Mellitus, Type 1
What this study did
NCT00505882 · University of Texas Southwestern Medical Center
2007-07 – 2008-12 · Type 1 Diabetes
What this study did
NCT00340613 · Baylor College of Medicine
2006-06 – 2007-06 · Type 1 Diabetes
What this study did
NCT00313742 · Novo Nordisk A/S
2006-04 – 2006-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00206401 · Baylor College of Medicine
2004-11 – 2006-10 · Type 1 Diabetes
What this study did
NCT00360984 · Newcastle University
2003-05 – 2004-09 · Type 1 Diabetes Mellitus
What this study did
NCT00276393 · Mayo Clinic
2002-07 – 2003-12 · Type 1 Diabetes
What this study did
Type 2 Diabetes
NCT07173712 · Yanbing Li
2026-03-15 – 2027-12-31 · Type 2 Diabetes
What this study did
NCT07307235 · Shanghai Zhongshan Hospital
2025-12-13 – 2027-12-30 · Type 2 Diabetes
What this study did
NCT06671587 · Sanofi
2024-12-10 – 2026-09-18 · Type 2 Diabetes (T2D)
What this study did
NCT06716424 · Sanofi
2025-01-06 – 2026-06-12 · Type 2 Diabetes
What this study did
NCT06370715 · Eli Lilly and Company
2024-04-18 – 2025-09-02 · Diabetes Mellitus, Type 2
What this study did
NCT05579119 · Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social
2022-07-06 – 2023-08-24 · Type 2 Diabetes
What this study did
NCT05552859 · Sanofi
2022-12-05 – 2023-08-04 · Type 2 Diabetes Mellitus, Renal Impairment
What this study did
NCT05114590 · Sanofi
2022-01-27 – 2023-04-14 · Type 2 Diabetes Mellitus
What this study did
NCT04893148 · Chungbuk National University Hospital
2020-05-26 – 2022-12-30 · Type 2 Diabetes Mellitus, Glucose, High Blood
What this study did
NCT03660553 · University of Miami
2018-10-10 – 2022-06-30 · Type 2 Diabetes Mellitus
What this study did
NCT04864977 · Eli Lilly and Company
2021-08-16 – 2022-06-06 · Type 2 Diabetes, Type 2 Diabetes Treated With Insulin
What this study did
NCT04567225 · The Cleveland Clinic
2020-10-01 – 2021-08-27 · Diabetic Ketoacidosis, Type 1 Diabetes, Type 2 Diabetes
What this study did
NCT04153981 · Eli Lilly and Company
2019-12-16 – 2021-07-30 · Type 2 Diabetes Mellitus
What this study did
NCT04196231 · University of Campania Luigi Vanvitelli
2019-11-27 – 2020-10-20 · Type 2 Diabetes
What this study did
NCT03670641 · Sandra Sobel
2019-03-26 – 2020-07-31 · Type 2 Diabetes Mellitus
What this study did
NCT03359837 · Sanofi
2018-01-20 – 2020-06-29 · Type 2 Diabetes Mellitus
What this study did
NCT03881995 · University Hospital Tuebingen
2019-03-18 – 2020-06-29 · Diabetes Mellitus, Type 2
What this study did
NCT02408120 · Emory University
2015-10 – 2019-12-11 · Diabetes Mellitus, Type 2
What this study did
NCT03631121 · Nanjing First Hospital, Nanjing Medical University
2018-08-15 – 2019-07-30 · Type2 Diabetes
What this study did
NCT02987751 · India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
2016-12-29 – 2019-06 · Type2 Diabetes
What this study did
NCT03659383 · Nanjing First Hospital, Nanjing Medical University
2018-09-20 – 2019-03-31 · Type2 Diabetes
What this study did
NCT02561130 · Population Health Research Institute
2015-12 – 2018-12-31 · Type 2 Diabetes Mellitus
What this study did
NCT03349840 · Weill Cornell Medical College in Qatar
2018-01-07 – 2018-12-31 · Type2 Diabetes
What this study did
NCT01717911 · Taipei Veterans General Hospital, Taiwan
2010-09 – 2018-12 · Type 2 Diabetes
What this study did
NCT03112538 · Clinical Research Centre, Malaysia
2016-01 – 2018-12 · Type 2 Diabetes Mellitus
What this study did
NCT03350984 · Universidad de Guanajuato
2017-11-02 – 2018-07-01 · Type 2 Diabetes Mellitus
What this study did
NCT04739241 · Consorci Sanitari Integral
2014-01-24 – 2018-06-19 · Type 2 Diabetes Treated With Insulin
What this study did
NCT02836704 · Sanofi
2016-09-09 – 2018-04-26 · Diabetes Mellitus, Type 2
What this study did
NCT02545842 · Sanofi
2015-09-07 – 2018-04-20 · Type 2 Diabetes Mellitus
What this study did
Early phase / not applicable (62)
Type 1 Diabetes
NCT06487598 · Hirabai Cowasji Jehangir Medical Research Institute
2024-07-01 – 2025-07 · Type 1 Diabetes
What this study did
NCT04383990 · King Abdullah International Medical Research Center
2020-02-28 – 2020-11-30 · Type1diabetes, Fasting, Insulin
What this study did
NCT03557892 · Azienda Ospedaliero-Universitaria Careggi
2018-04-01 – 2020-01-02 · Diabetes Mellitus, Type 1
What this study did
NCT02548494 · Chattanooga-Hamilton County Hospital Authority
2015-11 – 2019-02-01 · Diabetes Mellitus, Type 1, Diabetic Ketoacidosis
What this study did
NCT02824510 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
2014-08 – 2017-01 · Type 1 Diabetes
What this study did
NCT02871180 · Diabeteszentrum Bad Lauterberg im Harz
2003-03 – 2016-08 · Type 1 Diabetes, Hypoglycemia
What this study did
NCT02204839 · Northumbria University
2014-01 – 2015-01 · Type 1 Diabetes Mellitus
What this study did
NCT01424046 · University of Pittsburgh
2011-05 – 2014-11 · Type 1 Diabetes
What this study did
NCT00357890 · Nemours Children's Clinic
2005-12 – 2014-10 · Diabetes Mellitus, Insulin-Dependent
What this study did
NCT00564018 · University of Texas Southwestern Medical Center
2006-09 – 2011-04 · Type 1 Diabetes
What this study did
NCT00659165 · University of New Mexico
2008-04 – 2011-01 · Diabetes Mellitus
What this study did
NCT00417989 · Medtronic MiniMed, Inc.
2007-01 – 2010-06 · Type 1 Diabetes
What this study did
NCT00869414 · Johns Hopkins University
2009-07 – 2010-03 · Type 1 Diabetes, Hypoglycemia
What this study did
Type 2 Diabetes
NCT02879409 · Weill Cornell Medical College in Qatar
2016-11 – 2026-10-01 · Diabetes Mellitus Type 2
What this study did
NCT04553380 · Shenzhen Second People's Hospital
2020-12-01 – 2022-03-31 · Type 2 Diabetes
What this study did
NCT04074603 · Jian-hua Ma
2019-09-01 – 2021-12-31 · Type 2 Diabetes
What this study did
NCT04484779 · Eli Lilly and Company
2020-07-14 – 2020-12-22 · Type 1 Diabetes, Type 2 Diabetes
What this study did
NCT03829891 · Xijing Hospital
2018-08-07 – 2020-12-04 · Type 2 Diabetes Mellitus
What this study did
NCT03455985 · Ohio State University
2018-05-01 – 2020-09-11 · Diabetes Mellitus, Type 2, Patient Discharge, Blood Glucose, Low, Blood Glucose, High
What this study did
NCT03406663 · Seoul National University Hospital
2017-10-01 – 2020-07-14 · Type 2 Diabetes Mellitus
What this study did
NCT03180281 · First Affiliated Hospital Xi'an Jiaotong University
2017-07-01 – 2020-01-01 · Type 2 Diabetes Mellitus
What this study did
NCT03983187 · Majianhua
2019-06-15 – 2019-12-31 · Type 2 Diabetes
What this study did
NCT04093284 · Nanjing First Hospital, Nanjing Medical University
2019-09-12 – 2019-10-30 · Diabetes Mellitus, Type 2
What this study did
NCT02846233 · University of California, San Francisco
2016-08 – 2018-12 · Type 2 Diabetes Mellitus
What this study did
NCT02694289 · Maya Guglin
2016-11 – 2018-09-10 · Type 2 Diabetes Mellitus
What this study did
NCT01257087 · Imperial College London
2010-12 – 2016-08 · Type 2 Diabetes Mellitus, Obesity
What this study did
NCT02222623 · Inova Health Care Services
2015-04 – 2016-05 · Diabetes, Type 2
What this study did
NCT02026310 · Qifu Li
2014-01 – 2015-12 · Diabetes Mellitus, Type 2
What this study did
NCT02540486 · LMC Diabetes & Endocrinology Ltd.
2013-12 – 2015-03 · Type 2 Diabetes Mellitus
What this study did
NCT01089569 · HealthPartners Institute
2010-04 – 2013-05 · Type 2 Diabetes
What this study did
NCT01335763 · University of Alberta
2011-04 – 2012-10 · Type 2 Diabetes
What this study did
NCT00978263 · Chongqing Medical University
2009-02 – 2012-06 · Diabetes
What this study did
NCT00506194 · Taipei Veterans General Hospital, Taiwan
2005-10 – 2011-12 · Type 2 Diabetes
What this study did
NCT01334606 · Becton, Dickinson and Company
2011-03 – 2011-06 · Diabetes Mellitus, Type 2
What this study did
NCT01213563 · Imperial College London
2009-01 – 2010-09 · Diabetes Mellitus, Type 2
What this study did
NCT00948584 · Hallym University Medical Center
2007-11 – 2008-12 · Diabetes Mellitus, Type 2
What this study did
NCT00457093 · Diabetes Care Center
2006-10 – 2007-05 · Type 2 Diabetes
What this study did
Other / comorbidity
NCT07568574 · Enhanced Emirates Limited
2026-03-12 – 2033-03-01 · Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
What this study did
NCT07171684 · Rutgers, The State University of New Jersey
2025-11-26 – 2027-05-15 · Diabetes in Pregnancy, Gestational Diabetes
What this study did
NCT06419777 · Thomas Jefferson University
2024-09-01 – 2026-05 · Gestational Diabetes, Pregnancy Related
What this study did
NCT06419803 · Thomas Jefferson University
2024-09-01 – 2026-05 · Gestational Diabetes, Pregnancy Related
What this study did
NCT06178874 · Ain Shams University
2023-12-01 – 2024-06-01 · Glycemic Control, Insulin, Critical Illness
What this study did
NCT06056167 · King Faisal Specialist Hospital & Research Center
2023-05-17 – 2024-05-30 · Diabetes Mellitus, Critical Illness, Hyperglycemia
What this study did
NCT05219942 · Ain Shams University
2020-12-01 – 2022-07 · Chronic Kidney Diseases
What this study did
NCT02930044 · University of Maryland, Baltimore
2016-10 – 2021-11-01 · Diabetic Ketoacidosis
What this study did
NCT03001323 · Hennepin Healthcare Research Institute
2017-01 – 2020-09-25 · Diabetes Mellitus
What this study did
NCT01914146 · University of British Columbia
2015-04 – 2018-01-02 · Orthostatic Hypotension, Diabetes, Syncope
What this study did
Used as active comparator (158)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (73)
Type 1 Diabetes
NCT03740919 · Eli Lilly and Company
2019-04-07 – 2021-07-02 · Type 1 Diabetes Mellitus
What this study did
NCT03338023 · Eli Lilly and Company
2018-03-23 – 2020-03-05 · Type 1 Diabetes
What this study did
NCT04022993 · Geropharm
2018-07-04 – 2019-05-15 · Diabetes Mellitus, Type 1, Diabetes Mellitus
What this study did
NCT02666430 · Mylan Inc.
2015-12 – 2017-07 · Type 1 Diabetes Mellitus
What this study did
NCT02059161 · Merck Sharp & Dohme LLC
2013-10-17 – 2015-11-12 · Type 1 Diabetes Mellitus
What this study did
NCT01481779 · Eli Lilly and Company
2012-01 – 2014-06 · Diabetes Mellitus, Type 1
What this study did
NCT01421147 · Eli Lilly and Company
2011-08 – 2013-04 · Diabetes Mellitus, Type 1
What this study did
NCT01569841 · Novo Nordisk A/S
2012-04 – 2012-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01079234 · Novo Nordisk A/S
2010-03 – 2011-05 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00982228 · Novo Nordisk A/S
2009-09-01 – 2010-11-08 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT07920939 · Jiangsu HengRui Medicine Co., Ltd.
2026-11 – 2028-07 · Type 2 Diabetes
What this study did
NCT06767735 · Gan & Lee Pharmaceuticals.
2025-02-17 – 2026-08-17 · Diabetes
What this study did
NCT05098470 · University of Alabama at Birmingham
2022-03-07 – 2026-07-29 · Type 2 Diabetes
What this study did
NCT06767761 · Gan & Lee Pharmaceuticals.
2025-02-18 – 2026-04-09 · Diabetes
What this study did
NCT05803421 · Eli Lilly and Company
2023-04-03 – 2026-03-16 · Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease
What this study did
NCT06871761 · Jiangsu HengRui Medicine Co., Ltd.
2024-05-08 – 2025-05-13 · Adult Patients With Type 2 Diabetes
What this study did
NCT05699408 · Jiangsu HengRui Medicine Co., Ltd.
2023-03-31 – 2024-11-23 · Type 2 Diabetes
What this study did
NCT05702073 · Jiangsu HengRui Medicine Co., Ltd.
2023-03-31 – 2024-06-11 · Type 2 Diabetes Mellitus
What this study did
NCT05767255 · Hospital Universitario San Ignacio
2022-12-01 – 2023-08-30 · Diabetes Mellitus, Type 2 Treated With Insulin
What this study did
NCT04093752 · Eli Lilly and Company
2019-12-09 – 2021-11-24 · Type 2 Diabetes
What this study did
NCT03730662 · Eli Lilly and Company
2018-11-20 – 2021-04-22 · Type 2 Diabetes Mellitus
What this study did
NCT03338010 · Eli Lilly and Company
2018-03-22 – 2020-03-18 · Type 2 Diabetes
What this study did
NCT03371108 · Gan and Lee Pharmaceuticals, USA
2017-10-31 – 2019-04-17 · Diabetes Mellitus, Type 2
What this study did
NCT02501161 · Novo Nordisk A/S
2016-01-31 – 2018-10-03 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01621178 · Eli Lilly and Company
2012-07 – 2016-12 · Type 2 Diabetes, Chronic Kidney Disease
What this study did
NCT01959529 · Novo Nordisk A/S
2013-10-29 – 2016-10-16 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT02420262 · Novo Nordisk A/S
2015-07-26 – 2016-10-05 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT02302716 · Eli Lilly and Company
2014-12 – 2016-07 · Diabetes Mellitus, Type 2
What this study did
NCT02106364 · Eli Lilly and Company
2015-02 – 2016-06 · Diabetes Mellitus, Type 2
What this study did
NCT02128932 · Novo Nordisk A/S
2014-08-04 – 2015-09-03 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01894568 · Eli Lilly and Company
2013-07 – 2015-04 · Type 2 Diabetes Mellitus
What this study did
NCT02059187 · Merck Sharp & Dohme LLC
2014-02-11 – 2015-03-11 · Type 2 Diabetes Mellitus
What this study did
NCT01648582 · Eli Lilly and Company
2012-07 – 2014-12 · Type 2 Diabetes Mellitus
What this study did
NCT01952145 · Novo Nordisk A/S
2013-09-20 – 2014-11-04 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01435616 · Eli Lilly and Company
2011-11 – 2014-01 · Diabetes Mellitus, Type 2
What this study did
NCT01582451 · Eli Lilly and Company
2012-05 – 2013-12 · Diabetes Mellitus, Type 2
What this study did
NCT01468987 · Eli Lilly and Company
2011-12 – 2013-08 · Diabetes Mellitus, Type 2
What this study did
NCT01584232 · Eli Lilly and Company
2012-04 – 2013-07 · Type 2 Diabetes Mellitus
What this study did
Phase 2 (7)
Type 2 Diabetes
NCT06688123 · Jiangsu HengRui Medicine Co., Ltd.
2025-01-08 – 2026-04-22 · Type 2 Diabetes
What this study did
NCT03352674 · Universitas Indonesia
2016-09 – 2018-12-01 · Diabetes Mellitus
What this study did
NCT01027871 · Eli Lilly and Company
2010-01 – 2011-01 · Diabetes Mellitus, Type 2
What this study did
NCT00611884 · Novo Nordisk A/S
2008-01 – 2008-08 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00614055 · Novo Nordisk A/S
2008-01 – 2008-07 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00147745 · Daiichi Sankyo
2005-06 – 2008-01 · Type 2 Diabetes
What this study did
Other / comorbidity
NCT04591457 · Universitas Indonesia
2020-10 – 2021-08 · Diabetes Mellitus
What this study did
Phase 1 (34)
Type 1 Diabetes
NCT03400501 · Yale University
2017-10-01 – 2021-06-07 · Type 1 Diabetes Mellitus
What this study did
NCT03965013 · Novo Nordisk A/S
2019-06-05 – 2019-12-14 · Diabetes Mellitus, Type 1, Healthy Volunteers
What this study did
NCT02536859 · Novo Nordisk A/S
2015-08-31 – 2016-04-14 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01925989 · Eli Lilly and Company
2013-11 – 2015-10 · Type 1 Diabetes Mellitus
What this study did
NCT01771250 · Eli Lilly and Company
2013-10 – 2014-12 · Diabetes Mellitus, Type 1
What this study did
NCT01769404 · Eli Lilly and Company
2013-02 – 2013-12 · Diabetes Mellitus, Type 1
What this study did
NCT01784211 · Eli Lilly and Company
2013-02 – 2013-11 · Diabetes Mellitus, Type 1
What this study did
NCT01600950 · Eli Lilly and Company
2012-05 – 2012-07 · Diabetes Mellitus, Type 1
What this study did
NCT01114542 · Novo Nordisk A/S
2010-05-03 – 2010-08-10 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT01030926 · Novo Nordisk A/S
2009-12 – 2010-05 · Diabetes, Diabetes Mellitus, Type 1
What this study did
NCT00964418 · Novo Nordisk A/S
2009-08 – 2009-11 · Diabetes, Diabetes Mellitus, Type 1
What this study did
Type 2 Diabetes
NCT05596747 · Eli Lilly and Company
2022-11-30 – 2023-10-10 · Diabetes Mellitus, Type 2
What this study did
NCT04957914 · Eli Lilly and Company
2021-07-14 – 2022-10-17 · Type 2 Diabetes Mellitus
What this study did
NCT05248841 · Lannett Company, Inc.
2022-03-08 – 2022-08-31 · Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
What this study did
NCT04575181 · Novo Nordisk A/S
2020-10-21 – 2021-12-24 · Diabetes Mellitus, Type 2
What this study did
NCT04262661 · Novo Nordisk A/S
2020-03-02 – 2020-09-25 · Healthy Volunteers, Diabetes Mellitus, Type 2
What this study did
NCT04136067 · Novo Nordisk A/S
2019-10-29 – 2020-08-23 · Diabetes Mellitus, Type 2
What this study did
NCT03367377 · Eli Lilly and Company
2018-01-03 – 2018-10-03 · Diabetes Mellitus, Type 2
What this study did
NCT03095651 · Merck Sharp & Dohme LLC
2017-04-12 – 2018-01-30 · Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
What this study did
NCT02942914 · Eli Lilly and Company
2016-12-20 – 2017-10-18 · Diabetes Mellitus, Type 2
What this study did
NCT02197520 · Eli Lilly and Company
2014-07 – 2015-06 · Diabetes Mellitus, Type 2
What this study did
NCT01865292 · Novo Nordisk A/S
2006-08 – 2006-11 · Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
What this study did
Other / comorbidity
NCT03555305 · Eli Lilly and Company
2018-09-26 – 2019-11-04 · Healthy
What this study did
NCT03025009 · Eli Lilly and Company
2017-03-06 – 2018-04-11 · Healthy
What this study did
NCT02152384 · Eli Lilly and Company
2014-06 – 2014-12 · Diabetes Mellitus, Type 1
What this study did
NCT01654380 · Eli Lilly and Company
2012-07 – 2013-10 · Healthy Volunteers, Diabetes Mellitus, Type 1
What this study did
NCT01374178 · Eli Lilly and Company
2011-06 – 2011-07 · Diabetes Mellitus
What this study did
NCT00810589 · Medical University of Graz
2008-11 – 2008-12 · Diabetes, Type I
What this study did
NCT01497535 · Novo Nordisk A/S
2004-05-27 – 2004-10-31 · Diabetes, Healthy
What this study did
Phase 4 (36)
Type 1 Diabetes
NCT03668808 · Sansum Diabetes Research Institute
2018-11-16 – 2020-09-19 · Diabetes Mellitus, Type 1
What this study did
NCT02192450 · Nordsjaellands Hospital
2015-01 – 2019-02-28 · Type 1 Diabetes Mellitus, Nocturnal Hypoglycemia, Recurrent Severe Hypoglycaemia
What this study did
NCT01269034 · Albert Einstein College of Medicine
2010-12 – 2017-01-31 · Type 1 Diabetes
What this study did
NCT01269047 · Albert Einstein College of Medicine
2009-08 – 2016-12 · Type 1 Diabetes
What this study did
Type 2 Diabetes
NCT07112339 · Novo Nordisk A/S
2025-08-15 – 2028-03-23 · Diabetes Mellitus, Type 2
What this study did
NCT05553093 · Nanjing First Hospital, Nanjing Medical University
2022-03-15 – 2027-10-31 · Type 2 Diabetes Mellitus
What this study did
NCT03087032 · The First Affiliated Hospital of Xiamen University
2019-01-10 – 2025-02-10 · Type 2 Diabetes Patients, Overweight and Obesity, Hyperglycaemia (Diabetic)
What this study did
NCT06127433 · Sun Yat-sen University
2023-03-07 – 2024-12-30 · Insulin Pump,Continuous Glucose Monitoring Technology
What this study did
NCT03437330 · University Hospital Tuebingen
2021-10-27 – 2023-05-03 · Type2 Diabetes Mellitus
What this study did
NCT01107717 · The University of Texas Health Science Center at San Antonio
2009-01 – 2023-02-03 · Diabetes
What this study did
NCT05457933 · Medanta, The Medicity, India
2022-07-29 – 2023-01-14 · Type2diabetes, Coronary Artery Disease
What this study did
NCT05360537 · University of Palermo
2021-04-01 – 2022-04-20 · Diabetes Mellitus, Type 2
What this study did
NCT03336528 · Emory University
2018-01-02 – 2021-03-01 · Type 2 Diabetes
What this study did
NCT01919489 · Emory University
2014-03 – 2020-08-30 · Type 2 Diabetes
What this study did
NCT03687827 · Novo Nordisk A/S
2018-10-02 – 2019-12-27 · Diabetes Mellitus, Type 2
What this study did
NCT03819790 · LMC Diabetes & Endocrinology Ltd.
2018-10-02 – 2019-11-19 · Diabetes Mellitus, Type 2
What this study did
NCT02303730 · Fudan University
2015-03 – 2017-11 · Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease
What this study did
NCT02004366 · Emory University
2014-01 – 2017-03 · Type 2 Diabetes
What this study did
NCT02453685 · Novo Nordisk A/S
2015-08-31 – 2016-09-20 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT01845831 · Emory University
2013-08 – 2016-04 · Type 2 Diabetes
What this study did
NCT02072096 · Eli Lilly and Company
2014-02 – 2015-10 · Diabetes Mellitus, Type 2
What this study did
NCT02250794 · Rush University Medical Center
2014-10 – 2015-05 · Type 2 Diabetes Mellitus
What this study did
NCT00766857 · Amsterdam UMC, location VUmc
2009-05 – 2012-12 · Type 2 Diabetes Mellitus, Congestive Heart Failure
What this study did
NCT01100125 · Seoul National University Bundang Hospital
2010-04 – 2012-11 · Diabetes
What this study did
NCT01175811 · Eli Lilly and Company
2011-02 – 2012-11 · Diabetes Mellitus, Type 2
What this study did
NCT01175824 · Eli Lilly and Company
2011-04 – 2012-11 · Diabetes Mellitus, Type 2
What this study did
NCT01417897 · ikfe-CRO GmbH
2011-09 – 2012-05 · Type 2 Diabetes Mellitus
What this study did
NCT00664534 · Eli Lilly and Company
2008-04 – 2010-11 · Diabetes Mellitus, Type 2
What this study did
NCT00353834 · Joslin Diabetes Center
2006-08 – 2010-09 · Type 2 Diabetes Mellitus
What this study did
NCT00909480 · Novo Nordisk A/S
2009-05 – 2010-06 · Diabetes, Diabetes Mellitus, Type 2
What this study did
NCT00699686 · University of Padova
2008-05 – 2010-03 · Type 2 Diabetes, Endothelial Dysfunction, Cardiovascular Disease
What this study did
NCT00279201 · Eli Lilly and Company
2005-12 – 2009-11 · Diabetes Mellitus, Type 2
What this study did
NCT00548808 · Eli Lilly and Company
2007-11 – 2009-08 · Type 2 Diabetes Mellitus
What this study did
NCT00377858 · Eli Lilly and Company
2006-08 – 2008-09 · Diabetes Mellitus, Type 2
What this study did
Other / comorbidity
NCT02061969 · Emory University
2014-04-25 – 2017-04-10 · Diabetes
What this study did
NCT01854723 · Providence Health & Services
2013-04 – 2015-12 · Diabetes
What this study did
Early phase / not applicable (8)
Type 1 Diabetes
NCT04965051 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2021-08 – 2023-12 · Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range
What this study did
NCT04101383 · Geropharm
2017-10-16 – 2018-02-16 · Clamp Study
What this study did
Type 2 Diabetes
NCT07652528 · Hallym University
2026-08 – 2028-12 · Sudden Sensorineural Hearing Loss (SSNHL), Prediabetes / Type 2 Diabetes
What this study did
NCT03420040 · Xijing Hospital
2017-11-27 – 2018-04-01 · Type 2 Diabetes Mellitus
What this study did
NCT02887625 · Dr. Muhammad Abdulghani
2015-02 – 2017-05 · Type 2 Diabetes
What this study did
NCT01363609 · Amsterdam UMC, location VUmc
2011-10 – 2015-01 · Obesity, Type 2 Diabetes
What this study did
NCT00855439 · University of Michigan
2008-06 – 2014-05 · Type 2 Diabetes Mellitus, Diabetic Peripheral Neuropathy
What this study did
Other / comorbidity
NCT00574405 · Arkansas Children's Hospital Research Institute
2005-04 – 2011-03 · Diabetes Mellitus
What this study did
Appears in other studies (17)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (10)
Type 2 Diabetes
NCT04591626 · Eli Lilly and Company
2020-12-07 – 2022-04-28 · Type 2 Diabetes Mellitus
What this study did
NCT02738879 · Merck Sharp & Dohme LLC
2016-05-09 – 2018-01-30 · Type 2 Diabetes Mellitus
What this study did
NCT02033889 · Merck Sharp & Dohme LLC
2013-12-13 – 2017-08-03 · Type 2 Diabetes Mellitus
What this study did
NCT01698775 · Merck Sharp & Dohme LLC
2012-10-02 – 2016-01-19 · Type 2 Diabetes Mellitus
What this study did
NCT02152371 · Eli Lilly and Company
2014-05 – 2015-10 · Diabetes Mellitus, Type 2
What this study did
NCT01462266 · Merck Sharp & Dohme LLC
2012-01-13 – 2013-06-07 · Type 2 Diabetes Mellitus
What this study did
Phase 2 (3)
Type 1 Diabetes
NCT06111586 · Sanofi
2023-12-11 – 2030-10-29 · Type 1 Diabetes Mellitus
What this study did
Type 2 Diabetes
NCT00767000 · Merck Sharp & Dohme LLC
2008-10 – 2010-06 · Diabetes Mellitus, Type 2
What this study did
NCT00824616 · Merck Sharp & Dohme LLC
2009-01 – 2010-05 · Type 2 Diabetes Mellitus
What this study did
Phase 4 (4)
Type 2 Diabetes
NCT02811484 · Weill Medical College of Cornell University
2016-06 – 2018-12 · Diabetes Mellitus, Type 2
What this study did
NCT02556918 · Emory University
2016-01 – 2018-11-06 · Hyperglycemia
What this study did
Other / comorbidity
NCT02741687 · Emory University
2016-06 – 2017-04 · Hyperglycemia
What this study did
NCT02443402 · Emory University
2016-01 – 2016-12 · Coronary Artery Disease
What this study did

Competitive landscape

This mechanism is crowded: 12 other tracked programmes target it, none of them ahead of this one.

This drug's own stage for Type 1 Diabetes: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Insulin Glargine (Lantus): this drugApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
AfrezzaApprovedPeptideInsulinPartial signal
NCT04974528: HbA1c change at week 26 (ITT, n=117 vs 113): Afrezza +0.19 vs rapid-acting insulin analog +0.01; difference 0.18 percentage points (95% CI -0.07 to 0.44); non-inferiority (0.4% margin) not met, one-sided adjusted p=0.058. missed
NCT01445951: Change in HbA1c from baseline to week 24 (LS mean): Technosphere Insulin (Gen2 inhaler) plus basal insulin -0.21% vs insulin aspart plus basal insulin -0.40%; difference 0.19% (95% CI 0.02 to 0.36), inside the pre-specified non-inferiority margin of 0.4% (CT.gov posted analysis).
Insulin Aspart (NovoLog)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin Aspart (Fiasp)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin Degludec (Tresiba)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Detemir (Levemir)
ApprovedUS marketing discontinued
PeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glargine (Basaglar)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glargine (Toujeo)ApprovedPeptideInsulin receptor (basal)not yet gradedNo reviewed efficacy summary in this indication
Insulin Glulisine (Apidra)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin HumanApproved—Insulinnot yet gradedNo reviewed efficacy summary in this indication
Insulin Lispro (Humalog)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin Lispro (Lyumjev)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Insulin NPH (Humulin N)ApprovedPeptideInsulin receptornot yet gradedNo reviewed efficacy summary in this indication
Pramlintide (Symlin)
ApprovedUS marketing discontinued
PeptideAmylin receptornot yet gradedNo reviewed efficacy summary in this indication
CadisegliatinPhase 3Small moleculeGlucokinasenot yet gradedNo reviewed efficacy summary in this indication
Sotagliflozin (Inpefa)Phase 3Small moleculeSGLT1/2 (dual)not yet gradedNo reviewed efficacy summary in this indication
ZimislecelPhase 3Cell therapyPancreatic islet cells (VX-880 is a stem cell-derived therapy, not a small molecule drug), Pancreatic islet cell replacementnot yet gradedNo reviewed efficacy summary in this indication
IcovamenibPhase 2Small moleculeMeninnot yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(7 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Lantus (insulin glargine) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (1)
December 2026 (1)
Phase 4Type 1 DiabetesRecruiting
Est. primary completion 2026-12 · NCT03463564 · CT.gov ↗
What to watch
2027 (3)
June 2027 (2)
Phase 4Type 2 DiabetesNot yet recruiting
Est. primary completion 2027-06-30 · NCT07173712 · CT.gov ↗
What to watch
Phase 4Type 2 DiabetesRecruiting
Est. primary completion 2027-06-30 · NCT07307235 · CT.gov ↗
What to watch
December 2027 (1)
Phase 4Pregestational Diabetes, PregnancyRecruiting
Est. primary completion 2027-12-01 · NCT07224893 · CT.gov ↗
What to watch
2028 (2)
February 2028 (1)
Phase 4Steroid-Induced Diabetes, Steroid-Induced Hyperglycemia, DiabetesEnrolling by invitation
Est. primary completion 2028-02-09 · NCT07117240 · CT.gov ↗
What to watch
May 2028 (1)
Early phase / not applicableSafety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite AthletesEnrolling by invitation
Est. primary completion 2028-05-01 · NCT07568574 · CT.gov ↗
What to watch
2029 (1)
December 2029 (1)
Phase 4Gestational Diabetes Mellitus, Pregnancy, High RiskRecruiting
Est. primary completion 2029-12 · NCT06445946 · CT.gov ↗
What to watch

See the full readout calendar ↗

Regulatory and conference events

(1)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

17 December 2024ApprovalEgyptian approval of EVA Pharma's insulin glargine injection
EG, EDA · Source ↗